4MacKay JH, Arcuri KE, Goldberg AI, Snapinn SM, Sweet CS. Losartan and low-dose hydrochlorothiazide in patients with essential hypertension. A double-blind, placebo-controlled trial of concomitant administration compared with individual components[J]. Archives of Internal Medicine. Feb 12 1996, 156(3):278-285.
5Ferrario CM. The role of angiotensin antagonism in stroke prevention in patients with hypertension: focus on lusartan. Current medical research and opinion [J]. Nov 2004, 20 (11) : 1797-1804.
7Dezii CM. A retrospective study of persistence with single-pill combination therapy vs. concurrent two-pill therapy in patients with hypertansion [J]. Managed care(Langhome, Pa. Sep 2000, 9(9 Suppl) :2-6.
8Poluzzi E, Strahinja P, Vargiu A, Chiabrando G, Silvani MC, Motola D, Sangiorgi Cellini G, Vaccheri A, De PontiF. Montanaro N. Initial treatment of hypertension and adherence to therapy in general practice in Italy[J]. European Journal of Clinical Pharmacology. Sep 2005, 61 (8) :603-609.
9Conlin PR, Spenee JD, Williams B, Ribeiro AB, Saito I, Benedict C, Bunt AM.Angiotensin Ⅱ antagonists for hypertension: are there differences in efficacy[J] .Am J Hypertens.Apr 2000, 13(4 Pt 1) :418- 426.
10Critehley J, Gilchrist N, lkeda LS. A randomized, double-masked comparison of the antihypergtensive effecaey and safety of combination therapy with losartan and hydroehlorothiazide versus captoril and hydrochlorothiazide in elderly and younger patients[J]. Current Therapeutic Research. 1996, 57(5): 16.
二级参考文献3
1Unger T,Kaschina E. Drug interactions with angiotensin receptor blockers: a compqrison with other antihypertensives[J].Drug Sar,2003,26(10) :707 - 720
2Palmer AJ, Annemans L,Roze S, et al. Irbesartan is projected to be cost and life saving in a spanish setting for treatment of patients with type 2 diabetes, hypertension,and microalbuminuria[J]. Kidney Int Suppl,2005,(93) :52 - 54
